EUVIMEDEUVIMED entdecken
Crossref

Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis

Yuting Xie, Sirong Shi, Weitong Lv, Xinyu Wang, Lin Yue, Conghui Deng, Doudou Wang, Jing Han, Tinghong Ye iD, Yunfeng Lin iD

ACS Nano · 01.10.2024 · 18 (39) · 26704-26721

DOI: 10.1021/acsnano.4c06598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 14.09.2024. Verfasst von Yuting Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Gastrointestinal Cancer and Liver Disease, Department of Gastroenterology and Hepatology, State Key Laboratory of Biotherapy, West Chin…. Hauptthemen laut MEDLINE: Pyridones, Idiopathic Pulmonary Fibrosis, Antioxidants. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: West China School of Stomatology, Sichuan University, Science and Technology Department of Sichuan Province, Guizhou Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible lung disease, and developing an effective treatment remains a challenge. The limited therapeutic options are primarily delivered by the oral route, among which pirfenidone (PFD) improves pulmonary dysfunction and patient quality of life. However, its high dose and severe side effects (dyspepsia and systemic photosensitivity) limit its clinical value. Intratracheal aerosolization is an excellent alternative method for treating lung diseases because it increases the concentration of the drug needed to reach the focal site. Tetrahedral framework nucleic acid (tFNA) is a drug delivery system with exceptional delivery capabilities. Therefore, we synthesized a PFD-tFNA (Pt) complex using tFNA as the delivery vehicle and achieved quantitative nebulized drug delivery to the lungs via micronebulizer for lung fibrosis treatment. In vivo, Pt exhibited excellent immunomodulatory capacity and antioxidant effects. Furthermore, Pt reduced mortality, gradually restored body weight and improved lung tissue structure. Similarly, Pt also exhibited superior fibrosis inhibition in an in vitro fibrosis model, as shown by the suppression of excessive fibroblast activation and epithelial-mesenchymal transition (EMT) in epithelial cells exposed to TGF-β1. Conclusively, Pt, a complex with tFNA as a transport system, could enrich the therapeutic regimen for IPF via intratracheal aerosolization inhalation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesIdiopathic Pulmonary FibrosisAntioxidantsAnimalsHumansMiceNucleic AcidsDrug Delivery SystemsAnti-Inflammatory AgentsMice, Inbred C57BLMale

Stichwörter der Autor:innen

aerosolizationoxidative stresspirfenidonepulmonary fibrosistetrahedral framework nucleic acids

Substanzen

pirfenidonePyridonesAntioxidantsNucleic AcidsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Laboratory of Gastrointestinal Cancer and Liver Disease, Department of Gastroenterology and Hepatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
  • Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu 610041, China.
  • Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang 550000, China.
  • National Health Commission Key Laboratory for Diagnosis and Treatment of Pulmonary Immune Diseases, Guiyang 550000, China.

ORCID-Profile: Tinghong Ye, Yunfeng Lin

Förderung

  • West China School of Stomatology, Sichuan University
  • Science and Technology Department of Sichuan Province
  • Guizhou Provincial Science and Technology Department
  • National Natural Science Foundation of China

Zitieren

APA

Xie, Y., Shi, S., Lv, W., Wang, X., Yue, L., Deng, C., Wang, D., Han, J., Ye, T., & Lin, Y. (2024). Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis. ACS Nano, 18(39), 26704-26721. https://doi.org/10.1021/acsnano.4c06598

Vancouver

Xie Y, Shi S, Lv W, Wang X, Yue L, Deng C, et al. Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis. ACS Nano. 2024;18(39):26704-26721. doi:10.1021/acsnano.4c06598

BibTeX
@article{Xie2024,
  author = {Xie, Yuting and Shi, Sirong and Lv, Weitong and Wang, Xinyu and Yue, Lin and Deng, Conghui and Wang, Doudou and Han, Jing and Ye, Tinghong and Lin, Yunfeng},
  title = {Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {39},
  pages = {26704--26721},
  doi = {10.1021/acsnano.4c06598}
}
Kostenlos starten →